On 25 November 2025, Sanofi entered into a share purchase agreement to sell a 70% stake in the company operating its Lüleburgaz pharmaceutical manufacturing facility to Fareva, a world leader in industrial subcontracting for the pharmaceuticals, cosmetics, and industrial & household sectors. Sanofi will retain a 30% minority stake in the company.
The Lüleburgaz facility is one of Türkiye’s leading pharmaceutical manufacturing sites, with significant production capacity and export capabilities. The transaction is expected to close upon completion of customary regulatory approvals, including clearance from the Turkish Competition Authority.
Paksoy is pleased to announce that a team consisting of partner Stéphanie Beghe Sönmez, along with counsel Zeynep Toma and associates Selen Toma and Cansın Taner, is acting as counsel to Sanofi on this transaction.
Share
Related persons
You can contact us for detailed information.



Legal Information
This is for information purposes; it is not legal advice. As laws and their interpretation may change, please consult Turkish legal counsel to confirm the current position and obtain advice tailored to your circumstances before making any decision or taking action in relation to your matter in Türkiye. All rights reserved.
You May Be Interested In
30 September 2026
Paksoy advises the Kocadağ Family on the sale of its 70% stake in Espressolab
On 23 September 2026, the Kocadağ Family entered into a share purchase agreement to sell their 70% stake in Espressolab, a leading local…
28 September 2026
Serdar Paksoy, has been named Türkiye Litigator of the Year at the Benchmark Litigation Europe Awards 2026
We are pleased to announce that our Founder & Senior Partner, Serdar Paksoy, has been named Türkiye Litigator of the Year at the Benchmark…
17 September 2026
Paksoy advises Digital Realty on its entry into Türkiye through a joint venture with Rönesans Holding
Digital Realty, the world’s largest cloud- and carrier-neutral data center platform, has entered the Turkish market through a 50/50 joint…
7 September 2026
Paksoy advises EBRD on a USD 207 million loan to Enerjisa
Paksoy advises EBRD on a USD 207 million loan to Enerjisa. The loan will be used to finance the modernisation and construction investments…
31 August 2026
Paksoy advises Point72 on its investment in HubX
On 28 August 2026, Point72 Private Investments, one of the world’s leading alternative investment firms, completed an investment of up to…
10 August 2026
Paksoy closes Fysol’s acquisition of shares of Beşler Glass Fiber
Fysol, a France-headquartered player in the glass fiber industry backed by private equity firm Blantyre Capital, has completed the…
